Rubric Capital Management LP Cullinan Oncology, Inc. Transaction History

Rubric Capital Management LP

  • $3.38 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$9.72 - $13.62 $653,106 - $915,155
67,192 Added 12.0%
626,929 $6.61 Million
Q3 2022

Nov 14, 2022
BUY
$11.82 - $15.42 $3.1 Million - $4.05 Million
262,390 Added 88.24%
559,737 $7.18 Million
Q2 2022

Aug 15, 2022
BUY
$7.31 - $13.55 $2.17 Million - $4.03 Million
297,347 New
297,347 $3.81 Million

Others Institutions Holding CGEM

# of Institutions
140
Shares Held
65.9M
Call Options Held
77.2K
Put Options Held
15.9K
View Full List

About Cullinan Oncology, Inc.

CGEM Quotes by TradingView
  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $784M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email